Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:52 UTC |
---|
Update Date | 2022-03-07 02:52:02 UTC |
---|
HMDB ID | HMDB0015584 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Maraviroc |
---|
Description | Maraviroc (brand-named Selzentry, or Celsentri outside the U.S.) is a chemokine receptor antagonist drug developed by the drug company Pfizer that is designed to act against HIV by interfering with the interaction between HIV and CCR5. It was originally labelled as UK-427857 during development but was assigned the Maraviroc name as it entered trials. It was approved for use by the FDA in August, 2007. |
---|
Structure | [H][C@]12CC[C@]([H])(CC(C1)N1C(C)=NN=C1C(C)C)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)C1=CC=CC=C1 InChI=1S/C29H41F2N5O/c1-19(2)27-34-33-20(3)36(27)25-17-23-9-10-24(18-25)35(23)16-13-26(21-7-5-4-6-8-21)32-28(37)22-11-14-29(30,31)15-12-22/h4-8,19,22-26H,9-18H2,1-3H3,(H,32,37)/t23-,24+,25?,26-/m0/s1 |
---|
Synonyms | Value | Source |
---|
Selzentry | HMDB | Pfizer brand OF maraviroc | HMDB | 4,4-Difluoro-N-((1S)-3-(exo-3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo(3.2.1)oct-8-yl)-1-phenylpropyl)cyclohexanecarboxamide | HMDB | 4,4-Difluoro-N-[(1S)-3-[(1R,5S)-3-[3-methyl-5-(propan-2-yl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]cyclohexane-1-carboximidate | Generator | Maraviroc | MeSH |
|
---|
Chemical Formula | C29H41F2N5O |
---|
Average Molecular Weight | 513.6655 |
---|
Monoisotopic Molecular Weight | 513.327917369 |
---|
IUPAC Name | 4,4-difluoro-N-[(1S)-3-[(1R,5S)-3-[3-methyl-5-(propan-2-yl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]cyclohexane-1-carboxamide |
---|
Traditional Name | selzentry |
---|
CAS Registry Number | 376348-65-1 |
---|
SMILES | [H][C@]12CC[C@]([H])(CC(C1)N1C(C)=NN=C1C(C)C)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)C1=CC=CC=C1 |
---|
InChI Identifier | InChI=1S/C29H41F2N5O/c1-19(2)27-34-33-20(3)36(27)25-17-23-9-10-24(18-25)35(23)16-13-26(21-7-5-4-6-8-21)32-28(37)22-11-14-29(30,31)15-12-22/h4-8,19,22-26H,9-18H2,1-3H3,(H,32,37)/t23-,24+,25?,26-/m0/s1 |
---|
InChI Key | GSNHKUDZZFZSJB-HLMSNRGBSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as tropane alkaloids. These are organic compounds containing the nitrogenous bicyclic alkaloid parent N-Methyl-8-azabicyclo[3.2.1]Octane. |
---|
Kingdom | Organic compounds |
---|
Super Class | Alkaloids and derivatives |
---|
Class | Tropane alkaloids |
---|
Sub Class | Not Available |
---|
Direct Parent | Tropane alkaloids |
---|
Alternative Parents | |
---|
Substituents | - Tropane alkaloid
- Cyclohexyl halide
- Aralkylamine
- Monocyclic benzene moiety
- Piperidine
- N-alkylpyrrolidine
- Benzenoid
- Azole
- Pyrrolidine
- 1,2,4-triazole
- Heteroaromatic compound
- Amino acid or derivatives
- Carboxamide group
- Secondary carboxylic acid amide
- Tertiary amine
- Tertiary aliphatic amine
- Organoheterocyclic compound
- Azacycle
- Carboxylic acid derivative
- Amine
- Organooxygen compound
- Organonitrogen compound
- Organofluoride
- Organohalogen compound
- Organopnictogen compound
- Alkyl halide
- Carbonyl group
- Organic oxygen compound
- Organic nitrogen compound
- Alkyl fluoride
- Hydrocarbon derivative
- Organic oxide
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.011 g/L | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Maraviroc,1TMS,isomer #1 | CC1=NN=C(C(C)C)N1C1C[C@@H]2CC[C@H](C1)N2CC[C@@H](C1=CC=CC=C1)N(C(=O)C1CCC(F)(F)CC1)[Si](C)(C)C | 3651.2 | Semi standard non polar | 33892256 | Maraviroc,1TMS,isomer #1 | CC1=NN=C(C(C)C)N1C1C[C@@H]2CC[C@H](C1)N2CC[C@@H](C1=CC=CC=C1)N(C(=O)C1CCC(F)(F)CC1)[Si](C)(C)C | 3654.0 | Standard non polar | 33892256 | Maraviroc,1TMS,isomer #1 | CC1=NN=C(C(C)C)N1C1C[C@@H]2CC[C@H](C1)N2CC[C@@H](C1=CC=CC=C1)N(C(=O)C1CCC(F)(F)CC1)[Si](C)(C)C | 4578.5 | Standard polar | 33892256 | Maraviroc,1TBDMS,isomer #1 | CC1=NN=C(C(C)C)N1C1C[C@@H]2CC[C@H](C1)N2CC[C@@H](C1=CC=CC=C1)N(C(=O)C1CCC(F)(F)CC1)[Si](C)(C)C(C)(C)C | 3860.2 | Semi standard non polar | 33892256 | Maraviroc,1TBDMS,isomer #1 | CC1=NN=C(C(C)C)N1C1C[C@@H]2CC[C@H](C1)N2CC[C@@H](C1=CC=CC=C1)N(C(=O)C1CCC(F)(F)CC1)[Si](C)(C)C(C)(C)C | 3855.2 | Standard non polar | 33892256 | Maraviroc,1TBDMS,isomer #1 | CC1=NN=C(C(C)C)N1C1C[C@@H]2CC[C@H](C1)N2CC[C@@H](C1=CC=CC=C1)N(C(=O)C1CCC(F)(F)CC1)[Si](C)(C)C(C)(C)C | 4626.2 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Maraviroc GC-MS (Non-derivatized) - 70eV, Positive | splash10-0udj-5789500000-c1fbb569f8817687c0fb | 2017-09-01 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Maraviroc 10V, Positive-QTOF | splash10-03di-1411090000-7a0ec5b8cdb242a77d7e | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Maraviroc 20V, Positive-QTOF | splash10-004j-4932110000-8239e50aff7b5b385348 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Maraviroc 40V, Positive-QTOF | splash10-002g-9700000000-e3fbb3c26ff2f159ba12 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Maraviroc 10V, Negative-QTOF | splash10-03di-0100090000-0e449cf10d4204b39ea5 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Maraviroc 20V, Negative-QTOF | splash10-0459-1932530000-4b2b3bf87eab8b4ea67c | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Maraviroc 40V, Negative-QTOF | splash10-016r-3922000000-8e4bd2a074ad53969a06 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Maraviroc 10V, Positive-QTOF | splash10-03di-0000090000-396f6c6cc48f4b58c580 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Maraviroc 20V, Positive-QTOF | splash10-03di-0032290000-6567eec1e19f082e1b00 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Maraviroc 40V, Positive-QTOF | splash10-01r2-1900110000-60c11a36c4f938f71cf9 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Maraviroc 10V, Negative-QTOF | splash10-03di-0301090000-42af13f3f4888f175f96 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Maraviroc 20V, Negative-QTOF | splash10-03k9-3830590000-f63b8373e1a88dacc74d | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Maraviroc 40V, Negative-QTOF | splash10-01xx-4840920000-a408d897f59b74eddc6b | 2021-10-11 | Wishart Lab | View Spectrum |
|
---|